DNA
Ginkgo Bioworks Holdings
NYSE: DNA · HEALTHCARE · BIOTECHNOLOGY
$8.34
-9.17% today
Updated 2026-06-05
Market cap
$577.47M
P/E ratio
—
P/S ratio
3.81x
EPS (TTM)
$-5.38
Dividend yield
—
52W range
$5 – $18
Volume
1.3M
Ginkgo Bioworks Holdings (DNA) Insider transactions
Net insider activity
Net selling (402,181 shares)
Buy transactions
42
Sell transactions
58
All transactions
| Date | Insider | Title | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-04-17 | COEN, STEVEN P. | See remarks | Sale | 324 | $7.95 | $2576.45 |
| 2026-04-16 | COEN, STEVEN P. | See remarks | Sale | 587 | — | — |
| 2026-04-16 | COEN, STEVEN P. | See remarks | Sale | 156 | — | — |
| 2026-04-16 | COEN, STEVEN P. | See remarks | Buy | 587 | — | — |
| 2026-04-16 | COEN, STEVEN P. | See remarks | Buy | 156 | — | — |
| 2026-04-13 | COEN, STEVEN P. | See remarks | Sale | 33,171 | $6.41 | $212758.79 |
| 2026-04-10 | SHETTY, RESHMA P. | Director, See remarks, 10% Owner | Sale | 124,727 | $6.43 | $802493.52 |
| 2026-04-10 | COEN, STEVEN P. | See remarks | Sale | 45,553 | — | — |
| 2026-04-10 | COEN, STEVEN P. | See remarks | Sale | 28,368 | — | — |
| 2026-04-10 | COEN, STEVEN P. | See remarks | Buy | 45,553 | — | — |
| 2026-04-10 | COEN, STEVEN P. | See remarks | Buy | 28,368 | — | — |
| 2026-04-10 | CANTON, BARRY | 10% Owner | Sale | 124,727 | $6.43 | $802493.52 |
| 2026-04-09 | SHETTY, RESHMA P. | Director, See remarks, 10% Owner | Sale | 251,786 | — | — |
| 2026-04-09 | SHETTY, RESHMA P. | Director, See remarks, 10% Owner | Buy | 251,786 | — | — |
| 2026-04-09 | SHETTY, RESHMA P. | Director, See remarks, 10% Owner | Sale | 13,116 | $6.40 | $83903.05 |
| 2026-04-09 | KELLY, JASON R | Director, See remarks | Sale | 109,767 | $6.40 | $702179.50 |
| 2026-04-09 | CANTON, BARRY | 10% Owner | Sale | 251,786 | — | — |
| 2026-04-09 | CANTON, BARRY | 10% Owner | Buy | 251,786 | — | — |
| 2026-04-09 | CANTON, BARRY | 10% Owner | Sale | 13,116 | $6.40 | $83903.05 |
| 2026-04-08 | SHETTY, RESHMA P. | Director, See remarks, 10% Owner | Sale | 27,738 | — | — |
| 2026-04-08 | SHETTY, RESHMA P. | Director, See remarks, 10% Owner | Buy | 27,738 | — | — |
| 2026-04-08 | SHETTY, RESHMA P. | Director, See remarks, 10% Owner | Sale | 13,155 | $6.93 | $91164.15 |
| 2026-04-08 | KELLY, JASON R | Director, See remarks | Sale | 212,949 | — | — |
| 2026-04-08 | KELLY, JASON R | Director, See remarks | Buy | 212,949 | — | — |
| 2026-04-08 | KELLY, JASON R | Director, See remarks | Sale | 97,015 | $6.93 | $672313.95 |
| 2026-04-08 | CANTON, BARRY | 10% Owner | Sale | 27,738 | — | — |
| 2026-04-08 | CANTON, BARRY | 10% Owner | Buy | 27,738 | — | — |
| 2026-04-08 | CANTON, BARRY | 10% Owner | Sale | 13,155 | $6.93 | $91164.15 |
| 2026-04-07 | SHETTY, RESHMA P. | Director, See remarks, 10% Owner | Sale | 27,738 | — | — |
| 2026-04-07 | SHETTY, RESHMA P. | Director, See remarks, 10% Owner | Buy | 27,738 | — | — |
| 2026-04-07 | KELLY, JASON R | Director, See remarks | Sale | 212,949 | — | — |
| 2026-04-07 | KELLY, JASON R | Director, See remarks | Buy | 212,949 | — | — |
| 2026-04-07 | CANTON, BARRY | 10% Owner | Sale | 27,738 | — | — |
| 2026-04-07 | CANTON, BARRY | 10% Owner | Buy | 27,738 | — | — |
| 2026-03-16 | COEN, STEVEN P. | See remarks | Sale | 708 | $6.74 | $4768.38 |
| 2026-03-13 | COEN, STEVEN P. | See remarks | Sale | 1,174 | — | — |
| 2026-03-13 | COEN, STEVEN P. | See remarks | Sale | 312 | — | — |
| 2026-03-13 | COEN, STEVEN P. | See remarks | Buy | 1,174 | — | — |
| 2026-03-13 | COEN, STEVEN P. | See remarks | Buy | 312 | — | — |
| 2026-01-20 | COEN, STEVEN P. | See remarks | Sale | 972 | $8.92 | $8667.32 |
| 2026-01-16 | COEN, STEVEN P. | See remarks | Sale | 1,062 | — | — |
| 2026-01-16 | COEN, STEVEN P. | See remarks | Sale | 587 | — | — |
| 2026-01-16 | COEN, STEVEN P. | See remarks | Sale | 156 | — | — |
| 2026-01-16 | COEN, STEVEN P. | See remarks | Buy | 1,062 | — | — |
| 2026-01-16 | COEN, STEVEN P. | See remarks | Buy | 587 | — | — |
| 2026-01-16 | COEN, STEVEN P. | See remarks | Buy | 156 | — | — |
| 2025-12-15 | COEN, STEVEN P. | See remarks | Sale | 736 | $8.89 | $6540.10 |
| 2025-12-12 | COEN, STEVEN P. | See remarks | Sale | 1,174 | — | — |
| 2025-12-12 | COEN, STEVEN P. | See remarks | Sale | 312 | — | — |
| 2025-12-12 | COEN, STEVEN P. | See remarks | Buy | 1,174 | — | — |
| 2025-12-12 | COEN, STEVEN P. | See remarks | Buy | 312 | — | — |
| 2025-10-17 | COEN, STEVEN P. | See remarks | Sale | 1,312 | $13.65 | $17907.49 |
| 2025-10-16 | COEN, STEVEN P. | See remarks | Sale | 1,174 | — | — |
| 2025-10-16 | COEN, STEVEN P. | See remarks | Sale | 1,061 | — | — |
| 2025-10-16 | COEN, STEVEN P. | See remarks | Sale | 312 | — | — |
| 2025-10-16 | COEN, STEVEN P. | See remarks | Buy | 1,174 | — | — |
| 2025-10-16 | COEN, STEVEN P. | See remarks | Buy | 1,061 | — | — |
| 2025-10-16 | COEN, STEVEN P. | See remarks | Buy | 312 | — | — |
| 2025-10-01 | COEN, STEVEN P. | See remarks | Sale | 5,609 | $15.00 | $84135.00 |
| 2025-09-09 | HENRY, CHRISTIAN O | Director | Sale | 10,000 | $11.06 | $110600.00 |
| 2025-09-08 | HENRY, CHRISTIAN O | Director | Sale | 10,000 | $10.92 | $109200.00 |
| 2025-08-22 | COEN, STEVEN P. | See remarks | Sale | 310 | $12.40 | $3842.76 |
| 2025-08-21 | COEN, STEVEN P. | See remarks | Sale | 587 | — | — |
| 2025-08-21 | COEN, STEVEN P. | See remarks | Sale | 156 | — | — |
| 2025-08-21 | COEN, STEVEN P. | See remarks | Buy | 587 | — | — |
| 2025-08-21 | COEN, STEVEN P. | See remarks | Buy | 156 | — | — |
| 2025-07-17 | COEN, STEVEN P. | See remarks | Sale | 1,084 | $9.84 | $10668.73 |
| 2025-07-16 | COEN, STEVEN P. | See remarks | Sale | 1,174 | — | — |
| 2025-07-16 | COEN, STEVEN P. | See remarks | Sale | 1,061 | — | — |
| 2025-07-16 | COEN, STEVEN P. | See remarks | Sale | 312 | — | — |
| 2025-07-16 | COEN, STEVEN P. | See remarks | Buy | 1,174 | — | — |
| 2025-07-16 | COEN, STEVEN P. | See remarks | Buy | 1,061 | — | — |
| 2025-07-16 | COEN, STEVEN P. | See remarks | Buy | 312 | — | — |
| 2025-06-12 | SLOAN, HARRY | Director | Buy | 34,375 | — | — |
| 2025-06-12 | SANKAR, SHYAM | Director | Buy | 34,375 | — | — |
| 2025-06-12 | KOSURI, SRI | Director | Buy | 34,375 | — | — |
| 2025-06-12 | HENRY, CHRISTIAN O | Director | Buy | 34,375 | — | — |
| 2025-06-12 | FUBINI, ROSS | Director | Buy | 34,375 | — | — |
| 2025-06-11 | SLOAN, HARRY | Director | Sale | 10,822 | — | — |
| 2025-06-11 | SLOAN, HARRY | Director | Buy | 10,822 | — | — |
| 2025-06-11 | SANKAR, SHYAM | Director | Sale | 10,822 | — | — |
| 2025-06-11 | SANKAR, SHYAM | Director | Buy | 10,822 | — | — |
| 2025-06-11 | POTTER, MYRTLE S | Director | Sale | 10,822 | — | — |
| 2025-06-11 | POTTER, MYRTLE S | Director | Buy | 10,822 | — | — |
| 2025-06-11 | KOSURI, SRI | Director | Sale | 24,067 | — | — |
| 2025-06-11 | KOSURI, SRI | Director | Buy | 24,067 | — | — |
| 2025-06-11 | HENRY, CHRISTIAN O | Director | Sale | 10,822 | — | — |
| 2025-06-11 | HENRY, CHRISTIAN O | Director | Buy | 10,822 | — | — |
| 2025-06-11 | HANNAN, KATHY HOPINKAH | Director | Sale | 10,822 | — | — |
| 2025-06-11 | HANNAN, KATHY HOPINKAH | Director | Buy | 10,822 | — | — |
| 2025-06-11 | FUBINI, ROSS | Director | Sale | 10,822 | — | — |
| 2025-06-11 | FUBINI, ROSS | Director | Buy | 10,822 | — | — |
| 2025-05-21 | DMYTRUK, MARK E. | See remarks | Sale | 706 | $7.59 | $5355.01 |
| 2025-05-21 | COEN, STEVEN P. | See remarks | Sale | 346 | $7.59 | $2624.41 |
| 2025-05-20 | DMYTRUK, MARK E. | See remarks | Sale | 572 | — | — |
| 2025-05-20 | DMYTRUK, MARK E. | See remarks | Sale | 454 | — | — |
| 2025-05-20 | DMYTRUK, MARK E. | See remarks | Sale | 453 | — | — |
| 2025-05-20 | DMYTRUK, MARK E. | See remarks | Buy | 572 | — | — |
| 2025-05-20 | DMYTRUK, MARK E. | See remarks | Buy | 454 | — | — |
| 2025-05-20 | DMYTRUK, MARK E. | See remarks | Buy | 453 | — | — |
Frequently asked questions
Are DNA insiders buying or selling?
Over the transactions on record, DNA insiders have been net sellers, with about $3.91M in stock sold across 58 sales. The entries tagged as buys are stock grants and option exercises recorded at $0, not open-market purchases.
Does insider selling at DNA mean the stock will fall?
Not by itself. Most executive selling is pre-scheduled through 10b5-1 plans filed months in advance, and insiders sell for diversification, taxes, and liquidity far more often than out of any view on the price. Insider buying is the stronger signal, especially when several insiders buy around the same time, because there is usually only one reason to put personal cash into the stock.
Which DNA insiders are selling the most?
Recent selling is concentrated in a few names. KELLY, JASON R accounts for the largest share on record, with about $1.37M sold. Selling by one or two individuals matters less than broad selling across the whole leadership team, which is the pattern worth watching.